SBC Medical Group Holdings Incorporated announced SBC Wellness 2.0, a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. The initiative positions SBC Medical to participate in the fast-growing longevity market, which is projected to reach approximately $800 billion in 2025 and expand to approximately $2 trillion by 2035, with a compound annual growth rate exceeding 10% from 2026 to 2035. This strategy represents a natural extension of SBC Medical?s core business in Japan?s approximately $4 billion aesthetic healthcare market.
While Japan?s domestic longevity market has already reached an estimated $34 billion, it remains in its early stages with no clear market leader, providing a significant opportunity for the Company to capture first-mover advantages. SBC Medical intends to use its existing clinic network and customer base in Japan to build recurring revenue streams and a differentiated, data-rich platform. SBC Wellness 2.0 focuses on prevention, physical performance, and overall health span rather than only treating disease.
The service uses blood biomarkers, imaging, and AI tools to assess each customer?s condition and recommend personalized protocols that may include medical procedures, supplements, and lifestyle support. By integrating ?youthful appearance? and ?physical optimization,?
SBC Medical establishes a new ?performance medicine? category that goes beyond non-medical approaches like fitness and general supplements. The program follows a simple journey: measure key metrics, visualize biological age and risk, recommend a tailored plan, provide ongoing digital coaching, and track progress over time.
SBC Medical believes it is well-positioned in longevity, given its network of 283 clinics and about 6.5 million annual customer visits, which provide one of the largest aesthetic healthcare data sets in Japan. This large-scale data asset directly contributes to the advancement of proprietary AI models, establishing strong barriers to competitive entry. The Company operates on a medical platform that spans aesthetic healthcare procedures and insurance-covered care and has long experience serving repeat, premium clients.
Furthermore, SBC Medical?s expertise in high-value hospitality and user experience (UX) design, cultivated through its luxury clinic management, provides a meaningful advantage in meeting the needs of premium longevity customers. SBC Medical expects to commercialize Wellness 2.0 through a mix of bundled programs sold to corporations as employee-wellness benefits and higher-value, self-pay medical and aesthetic healthcare services sold directly to customers. The B2B model offers corporate clients a new form of human capital investment to enhance recruitment and reduce turnover, while providing the Company with an efficient growth model with low marketing costs.
Management believes this combination of subscription-like corporate contracts and discretionary medical services can support recurring revenue, higher retention, and improved unit economics over time.
